Optimal Therapeutic Intervention Timepoints for siRNA-Based Huntington's Disease Therapies
23rd to 23rd November 2021
Contact person: Bella Smith
Creative Biolabs has invited Dr. Markita Landry to walk us through how her team developed a near Infrared Catecholamine nanosensor (nIRCat) and used real-time imaging to find out what drives late-disease decreases in evoked dopamine release
Check the event website for more details.
View all events from this organizer.